T3 Defense Seeks Shareholder Approval for Highly Dilutive Securities and Reverse Split Amidst Delisting Risk

summarizeSummary

T3 Defense Inc. is calling a special meeting to approve highly dilutive warrant and preferred stock conversions from a prior $20M private placement, and a reverse stock split that the company warns will likely lead to Nasdaq delisting.

check_boxKey Events

• Shareholder Vote on Warrant Issuance

  Stockholders are asked to approve the issuance of 14,084,506 shares of common stock upon the exercise of warrants from a February 24, 2026 private placement, with an exercise price of $2.13 per share. The company anticipates registering for resale an amount equivalent to 250% of these shares, totaling 35,211,265 shares.

• Shareholder Vote on Preferred Stock Conversion

  Stockholders are asked to approve the issuance of shares upon conversion of Series B Convertible Preferred Stock from the same February 24, 2026 private placement. The preferred stock, which generated $20 million, is convertible at an initial price of $2.13 per share, potentially leading to an initial issuance of 9,389,670 shares, with up to 23,474,175 shares contemplated for resale registration. Failure to obtain approval by February 24, 2027, allows the holder to redeem shares at 105% of stated value.

• Potential Massive Dilution

  The combined potential issuance from warrants and preferred stock conversion (up to 58,685,440 shares) represents approximately 153% dilution to the 38,298,210 shares currently outstanding, based on the initial conversion/exercise prices.

• Reverse Stock Split Proposal

  The Board seeks discretionary authority for 18 months to effect a reverse stock split at a ratio between one-for-two and one-for-two hundred fifty, aimed at regaining Nasdaq's minimum bid price compliance.

auto_awesomeAnalysis

T3 Defense Inc. is seeking shareholder approval for three critical proposals that underscore its severe financial distress and precarious Nasdaq listing status. The company needs approval to issue shares from a February 2026 private placement involving warrants and convertible preferred stock, which could result in over 150% dilution to existing shareholders if fully exercised/converted. While the initial conversion/exercise price of $2.13 is above the current stock price of $0.60, the sheer volume of potential shares (over 58 million) represents a massive overhang. Most critically, the proposal for another reverse stock split, following three previous splits in the last two years, explicitly warns that this action will likely trigger an immediate delisting from Nasdaq. This filing reinforces the 'going concern' warning from the recent 10-K and signals an escalating struggle for survival and compliance.